Billings Clinic
Especially For:

Clinical Trials

Title   Leukemia (S0919): Relapsed Acute Myeloid Leukemia
Description   Phase II Study of Idarubicin and ARA C in Combination with Prevastin in Relapsed AML
IRB Number   SWOG S0919
Category   Leukemia
Inclusion/Notes   Must have received @ least 1 prior chemotherapy & achieved CR lasting @ least 3 mo. w relapse after last regimen
Refractory patients or those who received transplant are not eligible

Call Contact # below for further Inclusion/Exclusion criteria
Status   Active
Start Date   01/09/2009
Principal Investigator (PI)   Jorge Nieva, MD
Physician Profile   Hematology/Oncology
Contact Name   Linda Allen RN
Contact Email   lallen@billingsclinic.org
Phone   (406) 435-7484
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.